Scientists look to tears for clues to unlock ALS mysteries
NCT ID NCT04953286
Summary
This study aimed to find new ways to diagnose and track Amyotrophic Lateral Sclerosis (ALS) by analyzing chemicals in tears and cells from the eye's surface. Researchers compared 55 people with ALS to people without the disease to see if the chemical makeup of tears could serve as a reliable biomarker. The goal was to gather knowledge that could lead to better tools for diagnosis and predicting how the disease might progress, not to test a treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre d'Investigation Clinique_CIC 1415
Tours, France
-
Neurology Department, University Hospital of Tours, France
Tours, 37044, France
-
Ophthalmology Department, University Hospital of Tours, France
Tours, 37000, France
Conditions
Explore the condition pages connected to this study.